A chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxia
<p><strong>Background:</strong></p> The standard of care in general wards includes periodic manual measurements, with the data entered into track-and-trigger charts, either on paper or electronically. Wearable devices may support health care staff, improve patient safety, and...
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
JMIR Publications
2021
|
| _version_ | 1826308902168297472 |
|---|---|
| author | Morgado Areia, C Santos, M Vollam, S Pimentel, M Young, L Roman, C Ede, J Piper, P King, E Gustafson, O Harford, M Shah, A Tarassenko, L Watkinson, P |
| author_facet | Morgado Areia, C Santos, M Vollam, S Pimentel, M Young, L Roman, C Ede, J Piper, P King, E Gustafson, O Harford, M Shah, A Tarassenko, L Watkinson, P |
| author_sort | Morgado Areia, C |
| collection | OXFORD |
| description | <p><strong>Background:</strong></p>
The standard of care in general wards includes periodic manual measurements, with the data entered into track-and-trigger charts, either on paper or electronically. Wearable devices may support health care staff, improve patient safety, and promote early deterioration detection in the interval between periodic measurements. However, regulatory standards for ambulatory cardiac monitors estimating heart rate (HR) and respiratory rate (RR) do not specify performance criteria during patient movement or clinical conditions in which the patient’s oxygen saturation varies. Therefore, further validation is required before clinical implementation and deployment of any wearable system that provides continuous vital sign measurements.
<p><strong>Objective:</strong></p>
The objective of this study is to determine the agreement between a chest-worn patch (VitalPatch) and a gold standard reference device for HR and RR measurements during movement and gradual desaturation (modeling a hypoxic episode) in a controlled environment.
<p><strong>Methods:</strong></p>
After the VitalPatch and gold standard devices (Philips MX450) were applied, participants performed different movements in seven consecutive stages: at rest, sit-to-stand, tapping, rubbing, drinking, turning pages, and using a tablet. Hypoxia was then induced, and the participants’ oxygen saturation gradually reduced to 80% in a controlled environment. The primary outcome measure was accuracy, defined as the mean absolute error (MAE) of the VitalPatch estimates when compared with HR and RR gold standards (3-lead electrocardiography and capnography, respectively). We defined these as clinically acceptable if the rates were within 5 beats per minute for HR and 3 respirations per minute (rpm) for RR.
<p><strong>Results:</strong></p>
Complete data sets were acquired for 29 participants. In the movement phase, the HR estimates were within prespecified limits for all movements. For RR, estimates were also within the acceptable range, with the exception of the sit-to-stand and turning page movements, showing an MAE of 3.05 (95% CI 2.48-3.58) rpm and 3.45 (95% CI 2.71-4.11) rpm, respectively. For the hypoxia phase, both HR and RR estimates were within limits, with an overall MAE of 0.72 (95% CI 0.66-0.78) beats per minute and 1.89 (95% CI 1.75-2.03) rpm, respectively. There were no significant differences in the accuracy of HR and RR estimations between normoxia (≥90%), mild (89.9%-85%), and severe hypoxia (<85%).
<p><strong>Conclusions:</strong></p>
The VitalPatch was highly accurate throughout both the movement and hypoxia phases of the study, except for RR estimation during the two types of movements. This study demonstrated that VitalPatch can be safely tested in clinical environments to support earlier detection of cardiorespiratory deterioration. |
| first_indexed | 2024-03-07T07:26:08Z |
| format | Journal article |
| id | oxford-uuid:c17d60df-be2c-4ad3-8b1b-4e57b274a10a |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T07:26:08Z |
| publishDate | 2021 |
| publisher | JMIR Publications |
| record_format | dspace |
| spelling | oxford-uuid:c17d60df-be2c-4ad3-8b1b-4e57b274a10a2022-11-15T12:07:08ZA chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxiaJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c17d60df-be2c-4ad3-8b1b-4e57b274a10aEnglishSymplectic ElementsJMIR Publications2021Morgado Areia, CSantos, MVollam, SPimentel, MYoung, LRoman, CEde, JPiper, PKing, EGustafson, OHarford, MShah, ATarassenko, LWatkinson, P<p><strong>Background:</strong></p> The standard of care in general wards includes periodic manual measurements, with the data entered into track-and-trigger charts, either on paper or electronically. Wearable devices may support health care staff, improve patient safety, and promote early deterioration detection in the interval between periodic measurements. However, regulatory standards for ambulatory cardiac monitors estimating heart rate (HR) and respiratory rate (RR) do not specify performance criteria during patient movement or clinical conditions in which the patient’s oxygen saturation varies. Therefore, further validation is required before clinical implementation and deployment of any wearable system that provides continuous vital sign measurements. <p><strong>Objective:</strong></p> The objective of this study is to determine the agreement between a chest-worn patch (VitalPatch) and a gold standard reference device for HR and RR measurements during movement and gradual desaturation (modeling a hypoxic episode) in a controlled environment. <p><strong>Methods:</strong></p> After the VitalPatch and gold standard devices (Philips MX450) were applied, participants performed different movements in seven consecutive stages: at rest, sit-to-stand, tapping, rubbing, drinking, turning pages, and using a tablet. Hypoxia was then induced, and the participants’ oxygen saturation gradually reduced to 80% in a controlled environment. The primary outcome measure was accuracy, defined as the mean absolute error (MAE) of the VitalPatch estimates when compared with HR and RR gold standards (3-lead electrocardiography and capnography, respectively). We defined these as clinically acceptable if the rates were within 5 beats per minute for HR and 3 respirations per minute (rpm) for RR. <p><strong>Results:</strong></p> Complete data sets were acquired for 29 participants. In the movement phase, the HR estimates were within prespecified limits for all movements. For RR, estimates were also within the acceptable range, with the exception of the sit-to-stand and turning page movements, showing an MAE of 3.05 (95% CI 2.48-3.58) rpm and 3.45 (95% CI 2.71-4.11) rpm, respectively. For the hypoxia phase, both HR and RR estimates were within limits, with an overall MAE of 0.72 (95% CI 0.66-0.78) beats per minute and 1.89 (95% CI 1.75-2.03) rpm, respectively. There were no significant differences in the accuracy of HR and RR estimations between normoxia (≥90%), mild (89.9%-85%), and severe hypoxia (<85%). <p><strong>Conclusions:</strong></p> The VitalPatch was highly accurate throughout both the movement and hypoxia phases of the study, except for RR estimation during the two types of movements. This study demonstrated that VitalPatch can be safely tested in clinical environments to support earlier detection of cardiorespiratory deterioration. |
| spellingShingle | Morgado Areia, C Santos, M Vollam, S Pimentel, M Young, L Roman, C Ede, J Piper, P King, E Gustafson, O Harford, M Shah, A Tarassenko, L Watkinson, P A chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxia |
| title | A chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxia |
| title_full | A chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxia |
| title_fullStr | A chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxia |
| title_full_unstemmed | A chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxia |
| title_short | A chest patch for continuous vital sign monitoring: clinical validation study during movement and controlled hypoxia |
| title_sort | chest patch for continuous vital sign monitoring clinical validation study during movement and controlled hypoxia |
| work_keys_str_mv | AT morgadoareiac achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT santosm achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT vollams achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT pimentelm achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT youngl achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT romanc achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT edej achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT piperp achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT kinge achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT gustafsono achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT harfordm achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT shaha achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT tarassenkol achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT watkinsonp achestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT morgadoareiac chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT santosm chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT vollams chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT pimentelm chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT youngl chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT romanc chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT edej chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT piperp chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT kinge chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT gustafsono chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT harfordm chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT shaha chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT tarassenkol chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia AT watkinsonp chestpatchforcontinuousvitalsignmonitoringclinicalvalidationstudyduringmovementandcontrolledhypoxia |